期刊文献+

点击化学法制备奥曲肽类似物^(18)F-Ta-Gluc-TOCA及其生物学评价 被引量:2

Preparation of ^(18)F Labeled Octreotide Derivatives ^(18)F-Ta-Gluc-TOCA by Click Chemistry and its Biological Evaluation
下载PDF
导出
摘要 通过点击化学方法快速、方便合成18 F标记糖基化奥曲肽衍生物(18 F-Ta-Gluc-TOCA),探讨18F-Ta-Gluc-TOCA用作生长抑素受体阳性肿瘤显像的可能性。通过亲核取代制备2-18 F叠氮乙烷前体化合物,与奥曲肽前体Pr-Gluc-TOCA进行点击化学反应,经分离纯化后得到18 F-Ta-Gluc-TOCA。测定了标记物的体外稳定性和脂水分配系数,重点研究18 F-Ta-Gluc-TOCA在正常小鼠以及荷瘤裸鼠体内分布。结果表明,18F-Ta-Gluc-TOCA放化纯度为91%,体外稳定性良好,脂水分配系数为-0.43±0.05。正常小鼠体内生物分布结果表明:18F-Ta-Gluc-TOCA在血液中清除较快,主要通过肝脏代谢,部分经肾脏代谢。荷瘤裸鼠体内分布实验表明:18F-Ta-Gluc-TOCA在肿瘤中摄取较高,60min时达到(4.34±0.47)%ID/g,在120min时仍有较高的摄取。上述结果表明,18F-Ta-Gluc-TOCA有望用于生长抑素受体阳性肿瘤PET显像。 The preparation of 18F labeled peptides usually need many reaction steps, long time, harsh reaction conditions, which greatly limits the application of 18F labeled PET probe. Using click chemistry for the synthesis of 18F labeled peptides make the reaction con- ditions more reliable, efficient and selective. The reaction conditions are mild, low cost, and fast. The purpose of this research was to synthetize the glycosylated octreotide deriva- tive quickly and easily, to develop a method of 18F labeled peptides by click chemistry. We also discussed the exploration of the feasibility with 18F labeled glycosylated octreotide de- rivatives as a somatostatin receptor positive tumor probe. This work prepared 2-~ F-azide ethane precursor compounds by nucleophilic substitution and then labeled Pr-Gluc-TOCA by click chemistry, finally we got the product 18F-Ta-Gluc-TOCA by purification.
出处 《同位素》 CAS 2013年第2期91-97,109,共8页 Journal of Isotopes
关键词 18F 点击化学 奥曲肽类似物 18 F click chemistry octreotide derivatives
  • 相关文献

参考文献23

  • 1涂久生,吴佩,等.生长抑素及其类似物治疗肿瘤的研究进展[J].中国临床药理学与治疗学,2002,7(1):90-93. 被引量:4
  • 2王丽华,汪勇先,尹端沚.生长抑素及其类似物的标记技术的发展[J].核技术,2003,26(7):537-544. 被引量:6
  • 3武凤玉,左书耀.放射性核素标记奥曲肽肿瘤受体显像研究进展[J].国外医学(肿瘤学分册),2005,32(10):760-763. 被引量:6
  • 4Guhlke S, Wester HJ, Bruns C, et al. (2-[lSF] fluoropropionyl-(d) phel)- octreotide, a potential radiopharmaceutical for quantitative somatostatin receptor imaging with PET: Synthesis, radiolabel ing, in vitro validation and biodistribution in mice [J]. Nuclear Medicine and Biology, 1994, 21: 819-825.
  • 5Wester HJ, Brockmann J, Rosch F, et al. PET- Pharmacokinetics of 18 F-Octreotide : A Comparison with 67Ga_DFO_ and 86 Y-DTPA-Octreotide [J]. Nuclear Medicine & Biology, 1997, 24: 275-286.
  • 6Wester H J, Sehottelius M, Scheidhauer K, et al. PET imaging of somatostatin receptors: design, synthesis and preclinical evaluation of a novel 18F" labelled, carbohydrated analogue of octreotide[J]. European Journal of Nuclear Medicine and Molecu lar Imaging, 2003, 30: 117-122.
  • 7Meisetsehliger G, Poethko T, Stahl A, et al. Gluc-Lys(Es FFP)-TOCA PET in Patients with SSTR- Positive Tumors: Biodistribution and Diagnostic Evaluation Compared with [-H InDTPA- Octreotide[J]. The Journal of Nuclear Medcine, 2006, 47, 4:566 573.
  • 8Schirrmacher E, Wingler B, Cypryk M, et al. Synthesis of p (Di tert-butyl ETM F fluorosilyl) benzaldehyde (EJs FJSiFA-A) with High Specific Activity by Isotopic Exchange: A Convenient La- beling Synthon for the sF_Labeling of N amino- oxy Derivatized Peptides[J]. Bioconjugate Chem, 2007, 18:2 085-2 089.
  • 9Hohne A, Mu L, Honer M, et al. Synthesis, 18F- Labeling, and in Vitro and in Vivo Studies of Bombesin Peptides Modified with Silicon-Based Building Blocks [J]. Bioconjugate Chem, 2008, 19:1 871-1 879.
  • 10W/ingler C, Waser B, Alke A, et al. One-Step 18F-Labeling of Carbohydrate-Conjugated Octr- eotate-Derivatives Containing a Silicon-Fluoride Acceptor (SiFA) : In Vitro and in Vivo Evaluation as Tumor Imaging Agents for Positron Emission Tomography (PET) [J]. Bioconjugate Chem, 2010, 21 (12): 2 289-2 296.

二级参考文献222

  • 1朱小华,吴华.多肽的放射性标记[J].放射学实践,2004,19(11):850-852. 被引量:2
  • 2董卫莉,赵卫光,李玉新,刘征骁,李正名.“链接”化学及其应用[J].有机化学,2006,26(3):271-277. 被引量:15
  • 3Labroo V M, Hebel D, Kirk K L, et al. Int J Pept Protein Res, 1991, 37:430-439
  • 4Ogawa M, Hatano K, Oishi S, et al. Nucl Med Biol, 2003, 30:1-9
  • 5Schirrmacher R, Bradtmoller G, Schirrmacher E, et al. Angew Chem Int Ed, 2006, 45:6047-6050
  • 6Schirrmacher E, Wangler B, Cypryk M, et al. Bioconjugate Chem, 2007, 18:2085-2089
  • 7Rennen H J, Laverman P, Van Eerd J E, et al. Nucl Med Biol, 2007, 34:691-695
  • 8Lee Y S, Jeong J M, Kim H W, et al. Nucl Med Biol, 2006, 33:677-683
  • 9Bruus-Jensen K, Poethko T, Schottelius M, et al. Nucl Med Biol, 2006, 33:173-183
  • 10Jelinski M, Hamacher K, Coenen H H. J Label Compd Radiopharm, 2002, 45:217-229

共引文献58

同被引文献38

  • 1李娟,段明,张烈辉,蒋晓慧.点击化学及其应用[J].化学进展,2007,19(11):1754-1760. 被引量:30
  • 2Guhlke S,Wester HJ, Bruns C, et al. (2-[18F] fluoropropionyl-(D) phe 1)-octreotide, a potential radiopharmaceutical for quanti-tative somatostatin receptor imaging with PET: Synthesis, radio-labeling, in vitro validation and biodistribution in mice. Nucl MedBiol, 1994,21(6):819-825.
  • 3Wester HJ, Schottelius Mt Scheidhauer K, et al. PET imaging ofsomatostatin receptors: Design, synthesis and preclinical evalua-tion of a novel 18F-labelled, carbohydrated analogue of octreotide.Eur J Nucl Med Mol Imaging, 2003, 30(1) : 117-122.
  • 4Wuest F, Berndt M, Bergmann R, et al. Synthesis and applica-tion of [18 F] FDG-maleimidehexyloxime ( [18 F] FDG-MHO) : A[18F] FDG-based prosthetic group for the chemoselective 18F-la-beling of peptides and proteins. Bioconjug Chem, 2008,19(6):1202-1210.
  • 5Namavari M, Cheng Z,Zhang R, et al. A novel method for directsite-specific radiolabeling of peptides using [18F] FDG. BioconjugChem, 2009,20(3):432-436.
  • 6Poethko T, Schottelius M, Thumshirn G, et al. Two-step meth-odology for high-yield routine radiohalogenation of peptides: 18F-labeled RGD and octreotide analogs. J Nucl Med, 2004, 45(5):892-902.
  • 7Chang YS, Jeong JM, Lee YS, et al. Preparation of 18F-humanserum albumin: A simple and efficient protein labeling methodwith 18F using a hydrazone-formation method. Bioconjug Chem,2005,16(5):1329-1333.
  • 8Cai W, Zhang X, Wu Y, et al. A thiol-reactive 18F-labelingagent, N-C2-(4-18F-fluorobenzamido)ethyl] maleimide, and syn-thesis of RGD peptide-based tracer for PET imaging of alpha v be-ta 3 integrin expression. J Nucl Med, 2006, 47(7) : 1172-1180.
  • 9McBride WJ, Sharkey RM, Karacay H, et al. A novel methodof 18F radiolabeling for PET. J Nucl Med, 2009, 50 ( 6 ):991-998.
  • 10Laverman P, McBride WJ, Sharkey RM, et al. A novel facilemethod of labeling octreotide with 18F-fluorine. J Nucl Med,2010,51(3):4544-4561.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部